CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −366 | $72.97 | $27K | 149,612 |
| 2024-03-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −591 | $73.59 | $43K | 149,021 |
| 2024-03-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −351 | $74.78 | $26K | 148,670 |
| 2024-02-29 | Wassil Jim CHIEF OPERATING OFFICER | Grant or award 10b5-1 | +20,000 | 223,852 | ||
| 2024-02-29 | Wassil Jim CHIEF OPERATING OFFICER | Grant or award · Stock Option (right to buy) 10b5-1 | +90,000 | 90,000 | ||
| 2024-02-29 | Cowan Elvia SVP, FINANCE | Grant or award 10b5-1 | +5,400 | 13,158 | ||
| 2024-02-29 | Cowan Elvia SVP, FINANCE | Grant or award · Stock Option (right to buy) 10b5-1 | +25,000 | 25,000 | ||
| 2024-02-29 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Grant or award 10b5-1 | +10,500 | 31,210 | ||
| 2024-02-29 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Grant or award · Stock Option (right to buy) 10b5-1 | +50,000 | 50,000 | ||
| 2024-02-29 | GUGGENHIME ANDREW PRESIDENT AND CFO | Grant or award | +20,000 | 99,474 | ||
| 2024-02-29 | GUGGENHIME ANDREW PRESIDENT AND CFO | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2024-02-29 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +45,000 | 420,814 | ||
| 2024-02-29 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) 10b5-1 | +205,000 | 205,000 | ||
| 2024-02-26 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +30,000 | $1.79 | $54K | 405,814 |
| 2024-02-26 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −30,000 | $79.03 | $2.4M | 375,814 |
| 2024-02-26 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 30,225 | ||
| 2024-02-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +15,000 | $1.79 | $27K | 390,814 |
| 2024-02-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,356 | $75.15 | $177K | 388,458 |
| 2024-02-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,980 | $75.96 | $530K | 381,478 |
| 2024-02-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −5,545 | $76.95 | $427K | 375,933 |
Page 32 of 39 · 764 trades